Bellicum Pharmaceuticals, Inc. Gains 83.64%

Wed, Nov 15, 2023 at 07:48 PM
Bellicum Pharmaceuticals, Inc. Gains 83.64%

Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) soared at $0.19, representing a gain of 83.6%. On Wed, Nov 15, 2023, BLCM:NASDAQ hit a New 2-Week High of $0.19. From Wed, Nov 01, 2023, the stock recorded 10.00% Up Days and 9.09% Green Days

About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)

Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.